27th Aug 2020 16:22
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 26 August 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,590,391 | 1.23% | 471,233 | 0.37% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
355,000 | 0.28% | 388,411 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
1,945,391 | 1.51% | 859,644 | 0.67% |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 18 | 202.9144 USD |
Purchase | 50 | 197.7900 USD |
Purchase | 50 | 201.4700 USD |
Purchase | 100 | 197.5200 USD |
Purchase | 100 | 203.1700 USD |
Purchase | 200 | 198.0100 USD |
Purchase | 250 | 197.7600 USD |
Purchase | 915 | 198.3586 USD |
Purchase | 2,017 | 200.7815 USD |
Purchase | 2,244 | 201.3387 USD |
Purchase | 2,400 | 200.2735 USD |
Purchase | 2,450 | 200.2979 USD |
Purchase | 2,488 | 201.5700 USD |
Purchase | 37,874 | 201.0238 USD |
Purchase | 89,937 | 201.8069 USD |
Purchase | 90,737 | 201.8068 USD |
Sale | 18 | 202.9144 USD |
Sale | 100 | 196.1000 USD |
Sale | 100 | 202.1200 USD |
Sale | 200 | 202.0450 USD |
Sale | 300 | 201.8840 USD |
Sale | 400 | 201.9075 USD |
Sale | 402 | 199.1172 USD |
Sale | 704 | 202.3032 USD |
Sale | 950 | 200.4652 USD |
Sale | 1,036 | 201.5534 USD |
Sale | 1,100 | 201.9393 USD |
Sale | 1,113 | 201.7542 USD |
Sale | 1,500 | 200.1920 USD |
Sale | 1,515 | 198.1397 USD |
Sale | 1,744 | 202.5151 USD |
Sale | 1,880 | 201.8724 USD |
Sale | 1,942 | 201.8929 USD |
Sale | 1,950 | 200.1830 USD |
Sale | 2,100 | 201.7502 USD |
Sale | 2,386 | 201.9973 USD |
Sale | 2,987 | 201.5700 USD |
Sale | 3,105 | 201.7202 USD |
Sale | 3,180 | 201.9174 USD |
Sale | 3,880 | 201.7367 USD |
Sale | 3,891 | 201.6827 USD |
Sale | 4,250 | 202.0368 USD |
Sale | 6,031 | 201.8225 USD |
Sale | 6,739 | 201.9734 USD |
Sale | 34,464 | 200.9059 USD |
Sale | 52,425 | 201.7274 USD |
Sale | 90,737 | 201.8068 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 27 Aug 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200827005550/en/
Copyright Business Wire 2020
Related Shares:
Barclays